Qelbree
My Prescription
Payment
Select pharmacy
$398.67
Print or send this coupon to your phone
AlbertsonsPowered byPay as little as $0 for Qelbree
Works with your insurance. Enroll in the manufacturer's savings program in a few steps.
About Qelbree
Drug Details
Viloxazine, marketed as Qelbree, is a medication prescribed for the management of attention-deficit hyperactivity disorder (ADHD) in both children aged six and older, and adults. As part of a comprehensive treatment plan that includes psychological and social interventions, viloxazine helps enhance attention, focus, and reduce restlessness. Unlike many ADHD medications, Qelbree is not a controlled substance, minimizing concerns about abuse or dependency. This drug functions as a selective norepinephrine reuptake inhibitor (NRI), presumably by increasing norepinephrine levels in the brain, thereby potentially improving focus and decreasing impulsive behavior. It is taken orally once a day, and it may take at least a week to observe improvements in ADHD symptoms.
Price history for Qelbree
30 Capsule Extended Release 24 Hours, 200MG
Average retail price for Qelbree
Average SaveHealth price for Qelbree
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Qelbree dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 30 Capsule Extended Release 24 Hours | $398.94 | $13.30 |
| 150MG | 30 Capsule Extended Release 24 Hours | $398.77 | $13.29 |
| 200MG | 30 Capsule Extended Release 24 Hours | $398.87 | $13.30 |
| 200MG | 60 Capsule Extended Release 24 Hours | $780.74 | $13.01 |
Qelbree FAQs
Qelbree is a medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. It works by affecting certain neurotransmitters in the brain, which can help improve attention, focus, and impulse control. Unlike some other ADHD medications, Qelbree is not a stimulant.
It is important for a healthcare provider to evaluate the combination of Qelbree and Wellbutrin, as both medications can affect neurotransmitter levels in the brain. There may be an increased risk of side effects such as seizures when these medications are taken together. A healthcare provider can assess the potential risks and benefits and determine the appropriate treatment plan.
Qelbree (viloxazine hydrochloride) is a medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. The positive effects of Qelbree may include improved attention, reduced impulsivity, and decreased hyperactivity. It is a non-stimulant medication, which can be beneficial for individuals who may not respond well to stimulant medications or who experience undesirable side effects from them. Additionally, Qelbree has a lower potential for abuse compared to stimulant medications.
Qelbree (viloxazine hydrochloride) is a medication that affects the brain by modulating the levels of certain neurotransmitters, particularly norepinephrine. It is used to treat attention-deficit/hyperactivity disorder (ADHD) by helping to improve attention, focus, and impulse control. The exact mechanism of action is not fully understood, but it is believed to enhance the activity of norepinephrine in the brain, which plays a role in attention and behavior regulation.
It is important to consult a healthcare provider before combining Qelbree (viloxazine) with Wellbutrin (bupropion), as there may be potential interactions. Both medications can affect neurotransmitter levels in the brain, and a healthcare provider can assess the risks and benefits based on the individual's specific health needs and conditions.